Cardiff Oncology Inc (CRDF)
3.63
-0.11
(-2.94%)
USD |
NASDAQ |
May 17, 16:00
3.64
+0.01
(+0.28%)
After-Hours: 20:00
Cardiff Oncology Revenue (Quarterly): 0.205M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.205M |
| December 31, 2023 | 0.156M |
| September 30, 2023 | 0.141M |
| June 30, 2023 | 0.108M |
| March 31, 2023 | 0.083M |
| December 31, 2022 | 0.128M |
| September 30, 2022 | 0.093M |
| June 30, 2022 | 0.091M |
| March 31, 2022 | 0.074M |
| December 31, 2021 | 0.133M |
| September 30, 2021 | 0.086M |
| June 30, 2021 | 0.068M |
| March 31, 2021 | 0.072M |
| December 31, 2020 | 0.119M |
| September 30, 2020 | 0.136M |
| June 30, 2020 | 0.043M |
| March 31, 2020 | 0.068M |
| December 31, 2019 | 0.0926M |
| September 30, 2019 | 0.0517M |
| June 30, 2019 | 0.0383M |
| March 31, 2019 | 0.062M |
| December 31, 2018 | 0.078M |
| September 30, 2018 | 0.0884M |
| June 30, 2018 | 0.1118M |
| March 31, 2018 | 0.1001M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.185M |
| September 30, 2017 | 0.1233M |
| June 30, 2017 | 0.102M |
| March 31, 2017 | 0.095M |
| December 31, 2016 | 0.0681M |
| September 30, 2016 | 0.0891M |
| June 30, 2016 | 0.1034M |
| March 31, 2016 | 0.1205M |
| December 31, 2015 | 0.0792M |
| September 30, 2015 | 0.0573M |
| June 30, 2015 | 0.0585M |
| March 31, 2015 | 0.127M |
| December 31, 2014 | 0.0564M |
| September 30, 2014 | 0.0572M |
| June 30, 2014 | 0.0556M |
| March 31, 2014 | 0.111M |
| December 31, 2013 | 0.0474M |
| September 30, 2013 | 0.0438M |
| June 30, 2013 | 0.049M |
| March 31, 2013 | 0.1191M |
| December 31, 2012 | 0.1633M |
| September 30, 2012 | 0.2115M |
| June 30, 2012 | 0.0415M |
| March 31, 2012 | 0.0342M |
| December 31, 2011 | 0.0338M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0383M
Minimum
Jun 2019
0.205M
Maximum
Mar 2024
0.0993M
Average
0.0918M
Median
Revenue (Quarterly) Benchmarks
| BioVie Inc | -- |
| Perspective Therapeutics Inc | -- |
| Biolase Inc | 10.13M |
| Tenon Medical Inc | 0.808M |
| Adial Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.01M |
| Total Expenses (Quarterly) | 11.14M |
| EPS Diluted (Quarterly) | -0.22 |
| Enterprise Value | 95.16M |
| Profit Margin (Quarterly) | -4.88K% |
| Earnings Yield | -24.79% |
| Normalized Earnings Yield | -24.79 |